Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2006-11-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2006.08.171PMID 16979138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

  2006cited by this paper
• Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

  2006cited by this paper
• Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.

  2006cited by this paper
• Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor.

  2006cited by this paper
• Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma

  2006cited by this paper
• Podoplanin is expressed in subsets of tumors of the central nervous system

  2006cited by this paper
• D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas

  2005cited by this paper
• Enhanced Expression of Aggrus (T1alpha/Podoplanin), a Platelet-Aggregation-Inducing Factor in Lung Squamous Cell Carcinoma

  2005cited by this paper
• D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.

  2005cited by this paper
• Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling

  2005cited by this paper
• Podoplanin as a marker for mesothelioma

  2005cited by this paper
• Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.

  2005influential reference
• Functional Sialylated O-Glycan to Platelet Aggregation on Aggrus (T1α/Podoplanin) Molecules Expressed in Chinese Hamster Ovary Cells*

  2004influential reference
• Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood

  2004cited by this paper
• Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors

  2004cited by this paper
• Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors*

  2003influential reference
• Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.

  2001cited by this paper
• Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.

  1999cited by this paper
• LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan

  1999cited by this paper
• Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

  1995cited by this paper
• Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.

  1991cited by this paper
• Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation.

  1991cited by this paper
• Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies.

  1988cited by this paper
• The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation.

  1987cited by this paper
• Human platelet-tumor cell interactions vary with the tumor cell lines.

  1986cited by this paper
• ©1999 Cancer Research Campaign Article no. bjoc.1998.0393

  year unknowncited by this paper

• The unseen architects of metastasis: coagulation factors in pre-metastatic niche development.

  2026cites this paper
• Intrathoracic 90Y-NZ-16 therapy improves efficacy and reduces toxicity in pleural mesothelioma mice.

  2026cites this paper
• PMab-322: a novel anti-hippopotamus podoplanin monoclonal antibody for multiple applications

  2025cites this paper
• Antitumor Activities by a Humanized Cancer‐Specific Anti‐Podoplanin Monoclonal Antibody humPMab‐117 Against Human Tumors

  2025influential citation
• Epitope analysis of an anti-mouse CCR1 monoclonal antibody S15040E using flow cytometry

  2025cites this paper
• Evaluation of antibody variants using a ribosome display and Brevibacillus choshinensis secretion system.

  2025cites this paper
• Development of novel anti-rhinoceros podoplanin monoclonal antibodies for flow cytometry, western blotting, and immunohistochemistry

  2025cites this paper
• Development of a Sensitive Anti-Mouse CD39 Monoclonal Antibody (C39Mab-1) for Flow Cytometry and Western Blot Analyses

  2024cites this paper
• Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry

  2024cites this paper
• Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization

  2024cites this paper
• The regulation of cancer-associated thrombosis by podoplanin

  2024cites this paper
• A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models

  2024cites this paper
• Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry

  2024cites this paper
• Generation of Replication‐Competent Hepatitis B Virus Harboring Tagged Polymerase for Visualization and Quantification of the Infection

  2024cites this paper
• PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody

  2024cites this paper
• Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning

  2024cites this paper
• Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers

  2024cites this paper
• Epitope Mapping of an Anti-Mouse CCR8 Monoclonal Antibody C8Mab-2 Using Flow Cytometry

  2024influential citation
• Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies.

  2024cites this paper
• Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications

  2024cites this paper
• Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C44Mab-108 for Immunohistochemistry

  2023cites this paper
• Recombinant production of antibody antigen-binding fragments with an N-terminal human growth hormone tag in mammalian cells.

  2023cites this paper
• EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry

  2023cites this paper
• A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications

  2023cites this paper
• Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C44Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas

  2023cites this paper
• Epitope Mapping of an Anti-ferret Podoplanin Monoclonal Antibody Using the PA Tag-Substituted Analysis

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C44Mab-9 for Multiple Applications against Colorectal Carcinomas

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas

  2023cites this paper
• Kaposiform Hemangioendothelioma With Bone Destruction: A 16-Year Follow-Up Cohort Study of the Clinical Characteristics and Prognosis.

  2023cites this paper
• Promotion of squamous cell carcinoma tumorigenesis by oncogene‐mediated THG‐1/TSC22D4 phosphorylation

  2023cites this paper
• A Rat Anti-Mouse CD39 Monoclonal Antibody for Flow Cytometry

  2023cites this paper
• The role of podoplanin inhibitors in controlling oral cancer progression.

  2023cites this paper
• A Novel Anti-CD44 Variant 9 Monoclonal Antibody C44Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers

  2023cites this paper
• PMab-301: An Anti-Giraffe Podoplanin Monoclonal Antibody for Immunohistochemistry

  2023cites this paper
• Improved anti‐solid tumor response by humanized anti‐podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model

  2022cites this paper
• Development of a Monoclonal Antibody PMab-295 Against Elephant Podoplanin

  2022cites this paper
• Epitope Mapping of an Anti-elephant Podoplanin Monoclonal Antibody (PMab-295) Using Enzyme-Linked Immunosorbent Assay

  2022cites this paper
• Targeted delivery of lipid nanoparticle to lymphatic endothelial cells via anti-podoplanin antibody.

  2022cites this paper
• Development of a Monoclonal Antibody PMab-292 Against Ferret Podoplanin

  2022cites this paper
• Immunohistochemical Analysis Using Monoclonal Antibody PMab-269 Against Steller Sea Lion Podoplanin

  2022cites this paper
• Epitope Mapping Using the Cell-Based 2 × Alanine Substitution Method About the Anti-mouse CXCR6 Monoclonal Antibody, Cx6Mab-1

  2022cites this paper
• Roles of Podoplanin in Malignant Progression of Tumor

  2022cites this paper
• Development of Monoclonal Antibody 281-mG2a-f Against Golden Hamster Podoplanin

  2022cites this paper
• Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment

  2021cites this paper
• The structure of CLEC-2: mechanisms of dimerization and higher-order clustering

  2021cites this paper
• Role of Podoplanin-Positive Cells in Cardiac Fibrosis and Angiogenesis After Ischemia

  2021cites this paper
• Detection of REST expression in the testis using epitope‐tag knock‐in mice generated by genome editing

  2021cites this paper
• Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma

  2021cites this paper
• Development of a Novel Epitope Mapping System: RIEDL Insertion for Epitope Mapping Method

  2021cites this paper
• Epitope Mapping of an Antihuman EGFR Monoclonal Antibody (EMab-134) Using the REMAP Method

  2021cites this paper
• Epitope Mapping of the Anti-California Sea Lion Podoplanin Monoclonal Antibody PMab-269 Using Alanine-Scanning Mutagenesis and ELISA

  2021cites this paper
• Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin

  2021cites this paper
• Epitope Mapping of an Anti-Human Epidermal Growth Factor Receptor Monoclonal Antibody (EMab-51) Using the RIEDL Insertion for Epitope Mapping Method

  2021cites this paper
• Epitope Mapping of a Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (PcMab-60) Using Enzyme-Linked Immunosorbent Assay and Surface Plasmon Resonance

  2021cites this paper
• Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C44Mab-46) Using the REMAP Method

  2021cites this paper
• Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis

  2021cites this paper
• Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin

  2020cites this paper
• Crystal structure of an anti-podoplanin antibody bound to a disialylated O-linked glycopeptide.

  2020cites this paper
• Development and characterization of TrMab-6, a novel anti-TROP2 monoclonal antibody for antigen detection in breast cancer

  2020cites this paper
• Development of an Anti-Sheep Podoplanin Monoclonal Antibody PMab-256 for Immunohistochemical Analysis of Lymphatic Endothelial Cells

  2020cites this paper
• Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1

  2020cites this paper
• Epitope Mapping of PMab-241, a Lymphatic Endothelial Cell-Specific Anti-Bear Podoplanin Monoclonal Antibody

  2020cites this paper
• Podoplanin: a Prognostic Marker and a Potential Target for Therapy in Bladder Cancer

  2020cites this paper
• Podoplanin as an Attractive Target of CAR T Cell Therapy

  2020cites this paper
• Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the “Universal” CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2

  2020cites this paper
• Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells

  2020cites this paper
• Epitope Mapping of DhMab-1: An Antidiacylglycerol Kinase Monoclonal Antibody

  2020cites this paper
• Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients

  2020cites this paper
• Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System

  2020cites this paper
• Epitope Mapping of the Anti-Diacylglycerol Kinase Monoclonal Antibody DhMab-4 for Immunohistochemical Analysis

  2020cites this paper
• Moving toward generalizable NZ-1 labeling for 3D structure determination with optimized epitope-tag insertion

  2020cites this paper
• Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies

  2020cites this paper
• Epitope Analysis of an Anti-Whale Podoplanin Monoclonal Antibody, PMab-237, Using Flow Cytometry

  2020cites this paper
• Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma

  2020cites this paper
• Development and Characterization of Anti-Sheep Podoplanin Monoclonal Antibodies PMab-253 and PMab-260

  2020cites this paper
• An in vivo protease activity assay for investigating the functions of the Escherichia coli membrane protease HtpX

  2019cites this paper
• Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases

  2019cites this paper
• The Epitope of PMab-210 Is Located in Platelet Aggregation-Stimulating Domain-3 of Pig Podoplanin

  2019cites this paper
• PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis

  2019cites this paper
• Establishment of an Anticetacean Podoplanin Monoclonal Antibody PMab-237 for Immunohistochemical Analysis

  2019cites this paper
• Therapeutic efficacy evaluation of radioimmunotherapy with 90Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma

  2019cites this paper
• Association of high PDPN expression with pulmonary metastasis of osteosarcoma and patient prognosis

  2019cites this paper
• Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma

  2019cites this paper
• PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin

  2019cites this paper
• Development of an anti-bear podoplanin monoclonal antibody PMab-247 for immunohistochemical analysis

  2019cites this paper
• Epitope Mapping of Antihuman Diacylglycerol Kinase Gamma Monoclonal Antibody DgMab-6

  2019cites this paper
• Application of the NZ‐1 Fab as a crystallization chaperone for PA tag‐inserted target proteins

  2019cites this paper
• Epitope Mapping of Anti-Diacylglycerol Kinase Zeta Monoclonal Antibody DzMab-1 for Immunohistochemical Analyses

  2019cites this paper
• Immunohistochemical Analysis of the Harbor Porpoise Using Antipodoplanin Antibody PMab-237

  2019cites this paper
• Advances in domain and subunit localization technology for electron microscopy

  2019cites this paper
• The role of podoplanin in cancer-associated thrombosis.

  2018cites this paper
• Podoplanin: An emerging cancer biomarker and therapeutic target

  2018cites this paper
• Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front.

  2018cites this paper
• Establishment of Monoclonal Antibody PMab-202 Against Horse Podoplanin

  2018cites this paper
• Intermolecular autocatalytic activation of serine protease zymogen factor C through an active transition state responding to lipopolysaccharide

  2018cites this paper
• Roles of the CLEC-2–podoplanin interaction in tumor progression

  2018cites this paper
• Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis

  2018cites this paper
• Low Lymphatic Vessel Density Correlates with Lymph Node Metastasis in Oral Squamous Cell Carcinoma

  2018cites this paper
• The PA Tag: A Versatile Peptide Tagging System in the Era of Integrative Structural Biology.

  2018cites this paper